SUCCESSFUL TREATMENT AND PROPHYLAXIS OF SCALP SEBORRHEIC DERMATITIS AND DANDRUFF WITH 2-PERCENT KETOCONAZOLE SHAMPOO - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引:68
|
作者
PETER, RU [1 ]
RICHARZBARTHAUER, U [1 ]
机构
[1] JANSSEN RES FDN,W-4040 NEUSS,GERMANY
关键词
D O I
10.1111/j.1365-2133.1995.tb08680.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityrosporum ovale appears to play an important role in the pathogenesis of seborrhoeic dermatitis. Ketoconazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. We performed a multicentre study to investigate the efficacy of ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoeic dermatitis and dandruff. Five hundred and seventy-five patients presenting with moderate to severe seborrhoeic dermatitis and dandruff of the scalp were treated with 2% ketoconazole shampoo twice weekly for 2-4 weeks, producing an excellent response in 88%. Of those patients who responded, 312 were included in a prophylactic phase, lasting 6 months. These patients were treated with the active preparation (shampoo containing 2% ketoconazole) once-weekly, once every other week, alternating with placebo (shampoo without ketoconazole), or with placebo only once-weekly. Forty-eight (47%) patients in the placebo group experienced a relapse of seborrhoeic dermatitis compared with 23 (19%) patients in the active treatment group, and 31 (31%) patients in the active/placebo group. The medication was well tolerated in all three groups. We conclude that ketoconazole 2% shampoo is highly effective, not only in clearing scalp seborrhoeic dermatitis and dandruff, but also in preventing relapse of the disease when used prophylactically once weekly.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 50 条
  • [41] Efficacy and safety of avanafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Park, J. K.
    Zhao, C.
    Kim, S. W.
    Yang, D. Y.
    Kim, J. J.
    Park, N. C.
    Lee, S. W.
    Paick, J. S.
    Ahn, T. Y.
    Moon, K. H.
    Chung, W. S.
    Min, K. S.
    Suh, J. K.
    Hyun, J. S.
    Park, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E701 - U494
  • [42] POLYPODIUM LEUCOTOMOS EXTRACT IN ATOPIC DERMATITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND MULTICENTER CLINICAL TRIAL
    Ramirez-Bosca, A.
    Zapater Hernandez, P.
    Betlloch, I
    Albero, F.
    Martinez, A.
    De la Parte, Horga J. F.
    Diaz Alperi, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 28 - 28
  • [43] NIMODIPINE TREATMENT IN POOR-GRADE ANEURYSM PATIENTS - RESULTS OF A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    PETRUK, KC
    WEST, M
    MOHR, G
    WEIR, BKA
    BENOIT, BG
    GENTILI, F
    DISNEY, LB
    KHAN, MI
    GRACE, M
    HOLNESS, RO
    KARWON, MS
    FORD, RM
    CAMERON, GS
    TUCKER, WS
    PURVES, GB
    MILLER, JDR
    HUNTER, KM
    RICHARD, MT
    DURITY, FA
    CHAN, R
    CLEIN, LJ
    MAROUN, FB
    GODON, A
    JOURNAL OF NEUROSURGERY, 1988, 68 (04) : 505 - 517
  • [44] SAFETY AND EFFICACY OF DIVALPROEX SODIUM IN THE PROPHYLAXIS OF MIGRAINE HEADACHE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    SAPER, J
    MATHEW, N
    SILBERSTEIN, S
    NEUROLOGY, 1993, 43 (04) : A401 - A401
  • [45] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF KETOCONAZOLE AS A SINGLE TOPICAL APPLICATION IN THE TREATMENT OF TINEA-VERSICOLOR
    REKACEWICZ, I
    GUILLAUME, JC
    BENKHRABA, F
    ARCHIMBAUD, A
    BASPEYRAS, M
    BOITIER, F
    BUSSIERE, M
    COIN, A
    DICREZENZO, MC
    DUVAL, J
    EVENOU, P
    GIROUIN, D
    INTERLIGATOR, D
    LICHTENBERG, JP
    OEHMICHEN, O
    PATTIER, P
    POLI, F
    POUGET, F
    CHWETZOFF, E
    REVUZ, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1990, 117 (10): : 709 - 711
  • [46] DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NAPROXEN FOR THE TREATMENT OF DYSMENORRHEA
    DAWOOD, MY
    RIMANDORAMOS, J
    SPANN, J
    NILAND, N
    HALLADAY, S
    FRANCISCO, C
    SKARE, K
    BARTIZEK, R
    SORRENTINO, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 166 - 166
  • [47] A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus
    Westerberg, BD
    Roberson, JB
    Stach, BA
    AMERICAN JOURNAL OF OTOLOGY, 1996, 17 (06): : 896 - 903
  • [48] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [49] Impact of topiramate for migraine prophylaxis on workplace productivity: Results from a US randomized, double-blind, placebo-controlled, multicenter trial
    Lofland, JH
    Rupnow, MFT
    Gagne, JJ
    Smith, K
    Poston, S
    Pizzi, LT
    Papadopoulos, G
    NEUROLOGY, 2006, 66 (05) : A223 - A223
  • [50] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ACITRETIN FOR THE TREATMENT OF PSORIASIS
    OLSEN, EA
    WEED, WW
    MEYER, CJ
    COBO, LM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (04) : 681 - 686